Olink®Part of Thermo Fisher Scientific
Powerful, NGS-based proteomics - effortlessly uncover meaningful insights
A unique combination of specificity and scalability enables high-throughput, multiplex protein biomarker analysis.
Next-generation high-throughput proteomics empowers genetically-informed assessment of protein causality and the confident identification of novel drug targets.
Join the growing global community and consortia of Olink users to empower your biomarker discovery.
Over 3,400 and growing rapidly – covering all major disease areas
Your source for Olink’s terms, privacy policies, and compliance details
Filters
Nature Communications, 2022Multicenter phase II trial of Camrelizumab combined with Apatinib and Eribulin in heavily pretreated patients with advanced triple-negative breast cancer
Liu J., Wang Y., Tian Z. et al.
Olink Target 96
Journal of the American College of Cardiology, 2022Precision Phenotyping of Dilated Cardiomyopathy Using Multidimensional Data
Tayal U., Verdonschot J., Hazebroek M. et al.
Multiple Sclerosis and Related Disorders, 2022Biomarker panel increases accuracy for identification of an MS relapse beyond sNfL
Gawde S., Agasing A., Bhatt N. et al.
Atherosclerosis, 2022Socioeconomic disparity in cardiovascular disease: Possible biological pathways based on a proteomic approach
Shafi B., Bøttcher M., Ejupi A. et al.
Molecular Psychiatry, 2022Elevated endogenous GDNF induces altered dopamine signalling in mice and correlates with clinical severity in schizophrenia
Mätlik K., Garton D., Montaño-Rodríguez A. et al.
Annals of the Rheumatic Diseases, 2022Mechanism of action of baricitinib and identification of biomarkers and key immune pathways in patients with active systemic lupus erythematosus
Dörner T., Tanaka Y., Dow E. et al.
Thorax, 2022Relationship between impaired BMP signalling and clinical risk factors at early-stage vascular injury in the preterm infant
Heydarian M., Oak P., Zhang X. et al.
PROTEOMICS, 2022Stability and reproducibility of proteomic profiles in epidemiological studies: comparing the Olink and SOMAscan platforms
Haslam D., Li J., Dillon S. et al.
eBioMedicine, 2022The relationship between disease activity and UDCA response criteria in primary biliary cholangitis: A cohort study
Jones D., Wetten A., Barron-Millar B. et al.
Clinical Kidney Journal, 2022Kidney oxygenation, perfusion and blood flow in people with and without type 1 diabetes
Laursen J., Søndergaard-Heinrich N., Haddock B. et al.
Pediatric Research, 2022Validation of disease-specific biomarkers for the early detection of bronchopulmonary dysplasia
Kindt A., Förster K., Cochius-den Otter S. et al.
Scientific Reports, 2022Corticotropin releasing hormone as an identifier of bronchiolitis obliterans syndrome
Niroomand A., Ghaidan H., Hallgren O. et al.
eBioMedicine, 2022Higher levels of Bifidobacteria and tumor necrosis factor in children with drug-resistant epilepsy are associated with anti-seizure response to the ketogenic diet
Dahlin M., Singleton S., David J. et al.
Journal of Nephrology, 2022Assay-related differences in SuPAR levels: implications for measurement and data interpretation
Vasbinder A., Raffield L., Gao Y. et al.
Scientific Reports, 2022Circulating virome and inflammatory proteome in patients with ST-elevation myocardial infarction and primary ventricular fibrillation
Oliveras T., Revuelta-López E., García-García C. et al.
Cancers, 2022Type 2 Diabetes-Related Variants Influence the Risk of Developing Prostate Cancer: A Population-Based Case-Control Study and Meta-Analysis
Sánchez-Maldonado J., Collado R., Cabrera-Serrano A. et al.
Frontiers in Immunology, 2022The Genetic Risk for COVID-19 Severity Is Associated With Defective Immune Responses
Kuijpers Y., Chu X., Jaeger M. et al.
mBio, 2022Serine Protease Inhibitors Restrict Host Susceptibility to SARS-CoV-2 Infections
Rosendal E., Mihai I., Becker M. et al.
Olink Target 48
Nature Communications, 2022Contribution of rare whole-genome sequencing variants to plasma protein levels and the missing heritability
Kierczak M., Rafati N., Höglund J. et al.
Scandinavian Journal of Pain, 2022Association between systemic inflammation and experimental pain sensitivity in subjects with pain and painless neuropathy after traumatic nerve injuries
Miclescu A., Granlund P., Butler S. et al.
3478 publications
Items per page
2881-2900 of 3478 publications